Key highlights
- NCLT Ahmedabad admitted the CIRP petition against FTF Pharma on September 9, 2026.
- The petition filed by Immacule Lifesciences claims an operational debt of ₹2,18,03,319.
- FTF Pharma is a wholly owned subsidiary of Shilpa Medicare Limited.
- Sunil Kumar Kedia was appointed IRP and a Section 14 moratorium was imposed.
powered by IRIS
Shilpa Medicare Limited’s wholly owned subsidiary FTF Pharma entered the corporate insolvency resolution process after the NCLT Ahmedabad admitted a ₹2.18 crore operational-debt petition on September 9, 2026. The listed company said the effect on its financial and operational activities was not currently ascertainable or quantifiable.
Know Shilpa Medicare inside out
Results, valuation, peers and…